Are kidney stone surgeries putting patients at risk?

Image
ANI Washington D.C. [USA]
Last Updated : Jun 14 2017 | 2:48 PM IST

The techniques used to clean and sterilize flexible ureteroscopes leave behind contamination including debris, residue and bacteria, according to a new study.

The research, presented at the 44th Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC), concluded that these failures may result in the use of dirty scopes.

"APIC is concerned that the techniques used in the field are insufficient, and that current methods in place are introducing more contamination with the reprocessing of each scope," said Linda Greene, APIC president. "The results of this study are concerning and should prompt hospitals to ensure that proper cleaning verification and visual inspections are being performed."

The study, conducted by Ofstead & Associates, Inc., is the latest of its kind to raise concerns about infections associated with endoscopic procedures, as outbreaks have been linked to contaminated duodenoscopes, gastroscopes, bronchoscopes, and cystoscopes.

Ureteroscopy is a common outpatient surgical procedure. Doctors insert a thin, flexible scope into a patient's urinary tract to look for and remove kidney stones. Most flexible ureteroscopes are reused following cleaning and high-level disinfection or sterilization.

"This study underscores the importance of consistently monitoring reprocessing outcomes to ensure ureteroscopes are sterile and safe for patient use," said lead study author Cori Ofstead. "Sterilization failures were unexpected and are deeply concerning."

Researchers sampled 16 ureteroscopes at two institutions after they were cleaned and sterilized with hydrogen peroxide gas. They detected contamination on 100 percent of the scopes. Every scope exceeded the benchmark for protein, hemoglobin was found on 63 percent, and 44 percent had higher adenosine triphosphate (ATP) levels than anticipated. Visual inspections identified debris protruding into channels, oily deposits, and white foamy residue, an abnormality that researchers had never seen.

Reprocessing failures have also been found in other endoscopes. There are currently no reprocessing standards or benchmarks for permissible levels of residue specific to ureteroscopes. Therefore, the study used published benchmarks for manually cleaned gastrointestinal endoscopes, even though the level of residual contamination on sterilized ureteroscopes should be far lower than the amount allowed for clean gastrointestinal endoscopes. Sterilization is supposed to eradicate all viable microbes, and as such, microbial cultures should always be negative for sterilized instruments.

Researchers also tested two new ureteroscopes and found hemoglobin and protein levels increased after initial reprocessing--before they had ever been used. While no patients were involved in this study, Ofstead said the study is evidence that contaminated scopes are being used, with unknown implications for patients.

"Sterilization doesn't work if scopes aren't clean," Ofstead said. Noting that scopes are not routinely examined after reprocessing, she said, "If they had been conducting cleaning verification tests or visual inspections, every one of these scopes would have been removed from service. Every scope should be inspected, every time - and there must accountability measures set in place."

The study also uncovered a lack of bedside cleaning in the operating rooms, and long delays in processing of scopes after use, fundamental flaws that may have contributed to reprocessing failures.

The study appears in the American Journal of Infection Control.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 14 2017 | 2:48 PM IST

Next Story